Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the completed Phase 3 cervical cancer trial record, including its treatment arms, eligibility criteria, locations, outcomes, and supporting materials.
    Difference
    100%
    Check dated 2026-11-11T02:01:00.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:29:17.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence,” with a link to updates and FAQs. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:26:41.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-07T00:36:52.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the usual study content. This change replaces the study details with an error screen, indicating restricted access to the record.
    Difference
    20%
    Check dated 2026-09-23T00:40:46.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, representing a new version of the study page. This is a metadata/version control change and does not reflect changes to the study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-09-15T23:41:09.000Z thumbnail image

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.